Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • Request More Information
  • Journalists

Introducing Auryis AI-Powered Unified Compliance for Pharma & Life Sciences


News provided by

Canarys Automations Ltd

25 Aug, 2025, 09:00 IST

Share this article

Share toX

Share this article

Share toX

BENGALURU, India, Aug. 25, 2025 /PRNewswire/ -- Canarys (ISIN: INE0QG301017) is proud to announce the launch of Auryis, their AI-powered, unified compliance assessment platform purpose-built for Pharma and Life Sciences. This marks a pivotal step in Canarys' evolution—from a services-led organization to a product-led company.

Continue Reading
Celebrating the launch of Auryis, Canarys’ AI-powered unified compliance platform for Pharma and Life Sciences.
Celebrating the launch of Auryis, Canarys’ AI-powered unified compliance platform for Pharma and Life Sciences.

In a fast-changing regulatory landscape, Auryis delivers real-time, structured, and audit-ready compliance insights across all digital content—including SOPs, clinical trial documents, training materials, and marketing assets. It intelligently maps each element to external regulations (GxP, FDA, EMA), internal standards, and custom business rules—helping organizations anticipate and mitigate non-compliance risk before it escalates.

What sets Auryis apart:

  • Seamless content assessment: Ingests and analyses diverse formats, linking content to specific regulatory requirements.
  • Automated noncompliance detection: Flags non-compliance risks instantly and prioritizes critical issues for rapid resolution.
  • Human-in-the-loop intelligence: Enables SME review and feedback to continuously refine AI precision.
  • Custom rule integration: Adapts quickly to new policies, study conditions, and temporary guidance.
  • Continuous learning: Keeps pace with evolving global regulations, reducing manual workload and review cycles.

CEO, Canarys, Sheshadri Srinivas commented: "In today's complex regulatory environment, Pharma and Life Sciences organizations face mounting pressure—manual reviews, rapidly shifting global standards, and the costly consequences of compliance gaps that can delay approvals and impact patient safety.

Auryis addresses these challenges head-on, transforming compliance into a faster, smarter, and continuous process. Powered by AI and reinforced by expert validation, it delivers audit-ready insights, lowers non-compliance risk, and drives operational excellence.

This launch is a defining milestone in Canarys' journey. With Auryis, we are stepping confidently into a product-led future—creating durable value for our clients, investors, and partners."

Business impact at a glance:

  • Lower training burden through guided, standardized reviews
  • Significant cost and cycle-time reductions across content compliance
  • Proactive risk identification and mitigation
  • A sustainable shift toward continuous compliance improvement

Auryis: Compliance accelerated by AI, elevated by human expertise. Gain confidence, consistency, and operational excellence.

About Canarys

Canarys Automations Limited (formerly known as Canarys Automations Private Limited) headquartered in Bengaluru, India, boasts over 30 years of experience as a leading IT solutions provider. With a team of over 350 technology professionals, the company specializes in facilitating digital transformation for businesses through its software solutions in Digitalization, Modernization, Cloudification, Automation, and Intelligence. Their solutions cater to various industry sectors, including BFSI, Retail, Healthcare, Pharmaceutical, Manufacturing and Water Resources Management with a primary focus on enhancing operations, improving customer experience, and staying competitive.

For more information, visit www.ecanarys.com. 

Media Contact
Bharath S
[email protected] 

Logo: https://mma.prnewswire.com/media/2756165/Auryis_Launch.jpg

Modal title

Also from this source

Canarys Powers India's First-of-Its-Kind Urban Flood Management Cell, Inaugurated by Hon'ble CM Shri Yogi Adityanath in Gorakhpur

Canarys Powers India's First-of-Its-Kind Urban Flood Management Cell, Inaugurated by Hon'ble CM Shri Yogi Adityanath in Gorakhpur

Canarys Automations Ltd, (ISIN: INE0QG301017), a pioneering provider of innovative technology solutions and Water Resources Management packages,...

Canarys Automations Limited Expands North American Presence with Strategic Acquisition

Canarys Automations Limited Expands North American Presence with Strategic Acquisition

Canarys Automations Limited (NSE: CANARYS), a leading provider of digital transformation and technology solutions, has announced the successful...

More Releases From This Source

Explore

Computer & Electronics

Computer & Electronics

Artificial Intelligence

Artificial Intelligence

Computer Software

Computer Software

Computer Software

Computer Software

News Releases in Similar Topics

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.